酰胺质子转移成像联合FDG-PET/CT提高胶质瘤分级诊断准确性:基于连续净重分类分析的初步研究
回顾性纳入49例新诊断胶质瘤患者,评估酰胺质子转移成像联合[18F]FDG-PET及DWI对术前分级的附加价值。肿瘤/正常组织比值、最小ADC值和平均酰胺质子转移值鉴别高、低级别胶质瘤的诊断准确性相当;平均酰胺质子转移值联合肿瘤/正常组织比值时,诊断高级别胶质瘤和胶质母细胞瘤的连续净重分类改善分别为0.64(95%CI 0.036-1.24,P=0.04)和0.95(95%CI 0.39-1.52,P=0.001)。结论认为酰胺质子转移成像联合FDG-PET/CT可能提高鉴别高级别与低级别胶质瘤的能力。
要点
- 肿瘤/正常组织比值、最小ADC值和平均酰胺质子转移值鉴别高、低级别胶质瘤的准确性相当。
- 平均酰胺质子转移值联合肿瘤/正常组织比值诊断高级别胶质瘤的连续净重分类改善为0.64(P=0.04)。
- 平均酰胺质子转移值联合肿瘤/正常组织比值诊断胶质母细胞瘤的连续净重分类改善为0.95(P=0.001)。
核心结论
- 酰胺质子转移成像联合FDG-PET/CT可能提高鉴别高级别与低级别胶质瘤的能力。
研究设计与样本
- 回顾性研究纳入49例新诊断胶质瘤患者,均行3T MR成像(含DWI和酰胺质子转移成像)及[18F]FDG-PET检查。
诊断标准与关键数值
- 采用逻辑回归分析各影像参数与高级别(III级和/或IV级)胶质瘤的关系,参数包括FDG摄取肿瘤/正常组织比值、最小ADC值、平均酰胺质子转移值及其组合,并以受试者工作特征曲线评估鉴别效能;P<.05为显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Amide proton transfer imaging has been successfully applied to brain tumors, however, the relationships between amide proton transfer and other quantitative imaging values have yet to be investigated. The aim was to examine the additive value of amide proton transfer imaging alongside [18F] FDG-PET and DWI for preoperative grading of gliomas.
MATERIALS AND METHODS: Forty-nine patients with newly diagnosed gliomas were included in this retrospective study. All patients had undergone MR imaging, including DWI and amide proton transfer imaging on 3T scanners, and [18F] FDG-PET. Logistic regression analyses were conducted to examine the relationship between each imaging parameter and the presence of high-grade (grade III and/or IV) glioma. These parameters included the tumor-to-normal ratio of FDG uptake, minimum ADC, mean amide proton transfer value, and their combinations. In each model, the overall discriminative power for the detection of high-grade glioma was assessed with receiver operating characteristic curve analysis. Additive information from minimum ADC and mean amide proton transfer was also evaluated by continuous net reclassification improvement. P < .05 was considered significant.
RESULTS: Tumor-to-normal ratio, minimum ADC, and mean amide proton transfer demonstrated comparable diagnostic accuracy in differentiating high-grade from low-grade gliomas. When mean amide proton transfer was combined with the tumor-to-normal ratio, the continuous net reclassification improvement was 0.64 (95% CI, 0.036-1.24; P = .04) for diagnosing high-grade glioma and 0.95 (95% CI, 0.39-1.52; P = .001) for diagnosing glioblastoma. When minimum ADC was combined with the tumor-to-normal ratio, the continuous net reclassification improvement was 0.43 (95% CI, -0.17-1.04; P = .16) for diagnosing high-grade glioma, and 1.36 (95% CI, 0.79-1.92; P < .001) for diagnosing glioblastoma.
CONCLUSIONS: Addition of amide proton transfer imaging to FDG-PET/CT may improve the ability to differentiate high-grade from low-grade gliomas.
引用
- Sakata A, Okada T, Yamamoto Y, et al. Addition of Amide Proton Transfer Imaging to FDG-PET/CT Improves Diagnostic Accuracy in Glioma Grading: A Preliminary Study Using the Continuous Net Reclassification Analysis. AJNR Am J Neuroradiol. 2018. PMID: 29301781. doi:10.3174/ajnr.A5503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。